Overview of Infectious Diseases and Epidemiology, 2018 Introducing Merck, Gilead, Novavax and Johnson & Johnson – ResearchAndMarkets.com – Press Release



[ad_1]

DUBLIN – (Business Wire) – O "Infectious
Disease – Overview of Diseases and Epidemiology "
report of
Decision Resource Group was added to the ResearchAndMarkets.com
offer.

This report provides an overview of the disease market for each indication and
Overview of global epidemiology for each indication.

The Overview of Infectious Diseases and Epidemiology report provides the
market views and global epidemiological summaries for 10 indications in
the area of ​​therapy of Infectious Disease: Infection by Clostridium Difficile,
Gram-Negative Infections, Hospital-Treated, Methicillin Resistant
Staphylococcus Aureus Infections, Sepsis, Emerging Vaccines,
Cytomegalovirus (CMV), Hepatitis B Virus, Hepatitis C Virus, Human
Virus of Immunodeficiency and Respiratory Disease of the Syncytial Virus.

General views of the disease market include information such as market size
forecasts, trends analysis and treatment forecasts,
areas of unmet need, current and emerging therapies, physician (KOL)
insights, clinical pipeline analysis, and more, for each indication. O
General views of global epidemiology provide insights that include
prevalence diagnosed, prevalence diagnosed by region, diagnosis of 10 years
prediction of prevalence growth, relative sizes of factors
the trend in prevalent cases, and more, for each indication.

Key topics addressed:

  1. About the analyst

  2. About the epidemiology of the analyst

  3. Overview of Illness and Insight Overview

  4. Overview of epidemiology

Companies mentioned

  • Merck

  • Gilead

  • Novavax

  • Johnson & Johnson

For more information on this report, please visit https://www.researchandmarkets.com/research/998qr4/infectious?w=4

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For free calls in the US and Canada
1-800-526-8630
To GMT Office Hours Call + 353-1-416-8900
Related
Topics: Infectious
Diseases Drugs

[ad_2]

Source link